138 related articles for article (PubMed ID: 27725294)
41. miR-125a-5p expression is associated with the age of breast cancer patients.
He H; Xu F; Huang W; Luo SY; Lin YT; Zhang GH; Du Q; Duan RH
Genet Mol Res; 2015 Dec; 14(4):17927-33. PubMed ID: 26782438
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of microRNA-203a expression in breast cancer.
Gomes BC; Martins M; Lopes P; Morujão I; Oliveira M; Araújo A; Rueff J; Rodrigues AS
Oncol Rep; 2016 Sep; 36(3):1748-56. PubMed ID: 27431784
[TBL] [Abstract][Full Text] [Related]
43. Analysis of expression of microRNAs and genes involved in the control of key signaling mechanisms that support or inhibit development of brain tumors of different grades.
Koshkin PA; Chistiakov DA; Nikitin AG; Konovalov AN; Potapov AA; Usachev DY; Pitskhelauri DI; Kobyakov GL; Shishkina LV; Chekhonin VP
Clin Chim Acta; 2014 Mar; 430():55-62. PubMed ID: 24412320
[TBL] [Abstract][Full Text] [Related]
44. MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer.
Luo Q; Li X; Li J; Kong X; Zhang J; Chen L; Huang Y; Fang L
Int J Oncol; 2013 Oct; 43(4):1212-8. PubMed ID: 23900351
[TBL] [Abstract][Full Text] [Related]
45. miR-506 regulates breast cancer cell metastasis by targeting IQGAP1.
Sun G; Liu Y; Wang K; Xu Z
Int J Oncol; 2015 Nov; 47(5):1963-70. PubMed ID: 26398880
[TBL] [Abstract][Full Text] [Related]
46. Reconstructing the coding and non-coding RNA regulatory networks of miRNAs and mRNAs in breast cancer.
Yang S; Zhang H; Guo L; Zhao Y; Chen F
Gene; 2014 Sep; 548(1):6-13. PubMed ID: 24979338
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA profiling in intraocular medulloepitheliomas.
Edward DP; Alkatan H; Rafiq Q; Eberhart C; Al Mesfer S; Ghazi N; Al Safieh L; Kondkar AA; Abu Amero KK
PLoS One; 2015; 10(3):e0121706. PubMed ID: 25807141
[TBL] [Abstract][Full Text] [Related]
48. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
Deng X; Zhao Y; Wang B
Oncol Rep; 2015 Oct; 34(4):2188-94. PubMed ID: 26238950
[TBL] [Abstract][Full Text] [Related]
49. MiR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4.
Feng T; Xu D; Tu C; Li W; Ning Y; Ding J; Wang S; Yuan L; Xu N; Qian K; Wang Y; Qi C
Tumour Biol; 2015 Aug; 36(8):5987-97. PubMed ID: 25731732
[TBL] [Abstract][Full Text] [Related]
50. Prognostic and biological significance of microRNA-221 in breast cancer.
Eissa S; Matboli M; Sharawy A; El-Sharkawi F
Gene; 2015 Dec; 574(1):163-7. PubMed ID: 26253160
[TBL] [Abstract][Full Text] [Related]
51. miRNA-205 affects infiltration and metastasis of breast cancer.
Wang Z; Liao H; Deng Z; Yang P; Du N; Zhanng Y; Ren H
Biochem Biophys Res Commun; 2013 Nov; 441(1):139-43. PubMed ID: 24129185
[TBL] [Abstract][Full Text] [Related]
52. miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α.
Wu Z; Cai X; Huang C; Xu J; Liu A
Oncol Rep; 2016 Mar; 35(3):1696-702. PubMed ID: 26718330
[TBL] [Abstract][Full Text] [Related]
53. Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer.
Marques MM; Evangelista AF; Macedo T; Vieira RADC; Scapulatempo-Neto C; Reis RM; Carvalho AL; Silva IDCGD
Clinics (Sao Paulo); 2018 Jul; 73():e184. PubMed ID: 29995098
[TBL] [Abstract][Full Text] [Related]
54. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.
Li X; Zheng J; Chen L; Diao H; Liu Y
Mol Neurobiol; 2016 Jan; 53(1):577-583. PubMed ID: 25502291
[TBL] [Abstract][Full Text] [Related]
55. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
[TBL] [Abstract][Full Text] [Related]
56. Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.
Shishodia G; Shukla S; Srivastava Y; Masaldan S; Mehta S; Bhambhani S; Sharma S; Mehrotra R; Das BC; Bharti AC
Mol Cancer; 2015 Jun; 14():116. PubMed ID: 26051842
[TBL] [Abstract][Full Text] [Related]
57. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
Zhang Y; Xu G; Liu G; Ye Y; Zhang C; Fan C; Wang H; Cai H; Xiao R; Huang Z; Luo Q
Biochem Biophys Res Commun; 2016 Aug; 476(4):607-613. PubMed ID: 27264952
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
59. Association study of miR-22 and miR-335 expression levels and G2 assay related inherent radiosensitivity in peripheral blood of ductal carcinoma breast cancer patients.
Bakhtari N; Mozdarani H; Salimi M; Omranipour R
Neoplasma; 2021 Jan; 68(1):190-199. PubMed ID: 32853021
[TBL] [Abstract][Full Text] [Related]
60. Expression level of VLDL receptor and VLDL-c levels in the malignant and benign breast tumors: The correlation with miRNA-4465 and miRNA-1297.
Mosapour A; Karami Tehrani FS; Atri M
Mol Cell Probes; 2020 Oct; 53():101624. PubMed ID: 32711022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
